Your browser doesn't support javascript.
loading
Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
Tomita, Yoshihiko; Tatsugami, Katsunori; Nakaigawa, Noboru; Osawa, Takahiro; Oya, Mototsugu; Kanayama, Hiroomi; Nakayama Kondoh, Chihiro; Sassa, Naoto; Nishimura, Kazuo; Nozawa, Masahiro; Masumori, Naoya; Miyoshi, Yasuhide; Kuroda, Shingo; Tanaka, Shingo; Kimura, Akiko; Tamada, Satoshi.
Afiliación
  • Tomita Y; Department of Urology, Molecular Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Tatsugami K; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Nakaigawa N; Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Osawa T; Department of Renal and Genitourinary Surgery, Hokkaido University, Sapporo, Japan.
  • Oya M; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Kanayama H; Department of Urology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Nakayama Kondoh C; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
  • Sassa N; Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Nozawa M; Department of Urology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
  • Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Miyoshi Y; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
  • Kuroda S; Biostatistics, Japan Development Center, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Tanaka S; PRA Health Sciences Company Limited, Osaka, Japan.
  • Kimura A; Oncology Clinical Science, Oncology Therapeutic Area Unit for Japan and Asia, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Tamada S; Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Int J Urol ; 27(11): 952-959, 2020 11.
Article en En | MEDLINE | ID: mdl-32789967
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales / Antineoplásicos Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales / Antineoplásicos Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón